Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)
Clinical trial NCT07353437 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07353437
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2031-12-31
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.